Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 11Breast 4Lymphoid 2Genitourinary 2Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Endocrine 1

Conditions

Prostatic Neoplasms 2

Interventions

Docetaxel 409pembrolizumab 331Prednisone 289enzalutamide 283Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 252Abiraterone Acetate 217Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 117Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 106cabozantinib 104atezolizumab 104Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Diffusion Tensor Imaging × Genitourinary × Clear all
NCT04992728 2025-02-06

Prostate Assessment with Restriction Spectrum Imaging (RSI) MRI

University of California, San Diego

Recruiting
100 enrolled
Genitourinary

Prostatic Neoplasms

NCT02064283 2014-12-09

Early Assessment of Treatment Response Using Functional Diffusion Mapping

University of Michigan Rogel Cancer Center

Phase NA Completed
20 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡